Nanocarrier based drug delivery for rheumatoid arthritis: Current strategies and future directions
By: Na Li, Zefang Qu and Daodong Du
References
- S. Bayda, M. Adeel, T. Tuccinardi, M. Cordani and F. Rizzolio, The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine, Molecules 25(1) (2019) Article ID 112 (15 pages); https://doi.org/10.3390/molecules25010112
- N. Joudeh and D. Linke, Nanoparticle classification, physicochemical properties, characterization, and applications: A comprehensive review for biologists, J. Nanobiotechnol. 20(1) (2022) Article ID 262 (29 pages); https://doi.org/10.1186/s12951-022-01477-8
- A. Hasan, M. Morshed, A. Memic, S. Hassan, T. J. Webster and H. E. Marei, Nanoparticles in tissue engineering: Applications, challenges and prospects, Int. J. Nanomedicine 13 (2018) 5637–5655; https://doi.org/10.2147/IJN.S153758
- S. Malik, K. Muhammad and Y. Waheed, Emerging applications of nanotechnology in healthcare and medicine, Molecules 28(18) (2023) Article ID 6624 (30 pages); https://doi.org/10.3390/molecules28186624
- W. Yu, M. Chen, X. Tan, X. Wei, F. Sun, H. Yan, X. Xu and H. Shang, Traditional Chinese medicine modernization in diagnosis and treatment: Utilizing artificial intelligence and nanotechnology, MedComm. 7(2) (2026) Article ID e70596 (28 pages); https://doi.org/10.1002/mco2.70596
- R. Bilardo, F. Traldi, A. Vdovchenko and M. Resmini, Influence of surface chemistry and morphology of nanoparticles on protein corona formation, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 14(4) (2022) Article ID e1788 (22 pages); https://doi.org/10.1002/wnan.1788
- M. G. Soliman, A. Martinez-Serra, G. Antonello, M. Dobricic, T. Wilkins, T. Serchi, I. Fenoglio and M. P. Monopoli, Understanding the role of biomolecular coronas in human exposure to nanomaterials, Environ. Sci. Nano 11(11) (2024) 4421–4448; https://doi.org/10.1039/d4en00488d
- T. R. Kyriakides, A. Raj, T. H. Tseng, H. Xiao, R. Nguyen, F. S. Mohammed, S. Halder, M. Xu, M. J. Wu, S. Bao and W. C. Sheu, Biocompatibility of nanomaterials and their immunological properties, Biomed. Mater. 16(4) (2021) Article ID 042005 (49 pages); https://doi.org/10.1088/1748-605X/abe5fa
- T. M. Joseph, D. Kar Mahapatra, A. Esmaeili, L. Piszczyk, M. S. Hasanin, M. Kattali, J. Haponiuk and S. Thomas, Nanoparticles: Taking a unique position in medicine, Nanomaterials 13(3) (2023) Article ID 574 (58 pages); https://doi.org/10.3390/nano13030574
- H. Alshammari, M. M. A. Lashin, M. A. Mahmood, F. S. Al-Mubaddel, N. Ilyas, N. Rahman, M. Sohail, A. Khan, S. S. Abdullaev and R. Khan, Organic and inorganic nanomaterials: Fabrication, properties and applications, RSC Adv. 13(20) (2023) 13735–13785; https://doi.org/10.1039/d3ra01421e
- N. Desai, D. Rana, M. Patel, N. Bajwa, R. Prasad and L. K. Vora, Nanoparticle therapeutics in clinical perspective: Classification, marketed products, and regulatory landscape, Small 21(29) (2025) Article ID e2502315 (55 pages); https://doi.org/10.1002/smll.202502315
- F. Khalid-Salako, S. Salimi Khaligh, F. Fathi, O. C. Demirci, N. Oncer, H. Kurt and M. Yuce, The nanocarrier landscape – Evaluating key drug delivery vehicles and their capabilities: A translational perspective, ACS Appl. Mater. Interfaces 17(26) (2025) 37383–37403; https://doi.org/10.1021/acsami.5c07366
- K. M. Doroshenko and O. I. Shevchenko, From liposomes to virosomes: Evolution of phospholipid nanocarriers in drug delivery, Biotechnol. J. 21(1) (2026) Article ID e70178 (10 pages); https://doi.org/10.1002/biot.70178
- D. Hwang, J. D. Ramsey and A. V. Kabanov, Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval, Adv. Drug Deliv. Rev. 156 (2020) 80–118; https://doi.org/10.1016/j.addr.2020.09.009
- F. Abedi-Gaballu, G. Dehghan, M. Ghaffari, R. Yekta, S. Abbaspour-Ravasjani, B. Baradaran, J. E. N. Dolatabadi and M. R. Hamblin, PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy, Appl. Mater. Today 12 (2018) 177–190; https://doi.org/10.1016/j.apmt.2018.05.002
- M. D. Arpa and F. J. Akbuga, Chitosan-based nanogels in modern drug delivery: Focus on protein and gene applications, Gels 11(9) (2025) Article ID 735 (30 pages); https://doi.org/10.3390/gels11090735
- S. Pandey, F. Shaikh, A. Gupta, P. Tripathi and J. S. Yadav, A recent update: Solid lipid nanoparticles for effective drug delivery, Adv. Pharm. Bull. 12(1) (2022) 17–33; https://doi.org/10.34172/apb.2022.007
- M. Elmowafy and M. M. Al-Sanea, Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies, Saudi Pharm. J. 29(9) (2021) 999–1012; https://doi.org/10.1016/j.jsps.2021.07.015
- R. Narayan, U. Y. Nayak, A. M. Raichur and S. Garg, Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances, Pharmaceutics 10(3) (2018) Article ID 118 (49 pages); https://doi.org/10.3390/pharmaceutics10030118
- F. Eker, E. Akdasci, H. Duman, M. Bechelany and S. Karav, Gold nanoparticles in nanomedicine: Unique properties and therapeutic potential, Nanomaterials 14(22) (2024) Article ID 1854 (56 pages); https://doi.org/10.3390/nano14221854
- J. Dulinska-Litewka, A. Lazarczyk, P. Halubiec, O. Szafranski, K. Karnas and A. Karewicz, Super-paramagnetic iron oxide nanoparticles – Current and prospective medical applications, Materials 12(4) (2019) Article ID 617 (26 pages); https://doi.org/10.3390/ma12040617
- S. Hong, D. W. Choi, H. N. Kim, C. G. Park, W. Lee and H. H. Park, Protein-based nanoparticles as drug delivery systems, Pharmaceutics 12(7) (2020) Article ID 604 (29 pages); https://doi.org/10.3390/pharmaceutics12070604
- A. K. Balaraman, M. Arockia Babu, M. Afzal, G. Sanghvi, M. M. R., S. Gupta, M. Rana, H. Ali, K. Goyal, V. Subramaniyan, L. S. Wong and V. Kumarasamy, Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells, Regen. Ther. 28 (2025) 558–572; https://doi.org/10.1016/j.reth.2025.01.019
- S. Jacob, N. R. Varkey, S. H. S. Boddu, B. Gorain, R. Rao and A. B. Nair, Advances in lipid-polymer hybrid nanoparticles: Design strategies, functionalization, oncological and non-oncological clinical prospects, Pharmaceuticals 18(12) (2025) Article ID 1772 (41 pages); https://doi.org/10.3390/ph18121772
- M. Zhang, W. Hu, C. Cai, Y. Wu, J. Li and S. Dong, Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment, Mater. Today Bio 14 (2022) Article ID 100223 (18 pages); https://doi.org/10.1016/j.mtbio.2022.100223
- Q. Chen, Z. Zheng, M. Lin, Z. Guo, H. Huang, Q. Xue, S. Jiang, J. Wang and A. Wu, Nanocomposite hydrogels: A promising approach for the treatment of degenerative joint diseases, Small Sci. 4(11) (2024) Article ID 2400236 (34 pages); https://doi.org/10.1002/smsc.202400236
- M. M. Ramesh, R. Lobo and A. H. Venkatappa, Pharmacological enhancement of anti-inflamma tory drug efficacy through solid lipid nanoparticles in osteoarthritis and rheumatoid arthritis: A review, Inflammopharmacology 34(4) (2026) 2043–2060; https://doi.org/10.1007/s10787-026-02205-6
- Y. Liu, Z. Lin, Y. Wang, L. Chen, Y. Wang and C. Luo, Nanotechnology in inflammation: Cutting--edge advances in diagnostics, therapeutics and theranostics, Theranostics 14(6) (2024) 2490–2525; https://doi.org/10.7150/thno.91394
- X. Yang, Y. Chang and W. Wei, Endothelial dysfunction and inflammation: Immunity in rheumatoid arthritis, Mediators Inflamm. 2016 (2016) Article ID 6813016 (9 pages); https://doi.org/10.1155/2016/6813016
- Z. Ci, H. Wang, J. Luo, C. Wei, J. Chen, D. Wang and Y. Zhou, Application of nanomaterials targeting immune cells in the treatment of chronic inflammation, Int. J. Nanomedicine 19 (2024) 13925–13946; https://doi.org/10.2147/IJN.S497590
- F. U. Din, W. Aman, I. Ullah, O. S. Qureshi, O. Mustapha, S. Shafique and A. Zeb, Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors, Int. J. Nanomedicine 12 (2017) 7291–7309; https://doi.org/10.2147/IJN.S146315
- X. Liu, Z. Wang, H. Qian, W. Tao, Y. Zhang, C. Hu, W. Mao and Q. Guo, Natural medicines of targeted rheumatoid arthritis and its action mechanism, Front. Immunol. 13 (2022) Article ID 945129 (19 pages); https://doi.org/10.3389/fimmu.2022.945129
- T. Benameur, S. V. Frota Gaban, G. Giacomucci, F. M. Filannino, T. Trotta, R. Polito, G. Messina, C. Porro and M. A. Panaro, The effects of curcumin on inflammasome: Latest update, Molecules 28(2) (2023) Article ID 742 (19 pages); https://doi.org/10.3390/molecules28020742
- J. Ptacek, R. E. Hawtin, D. Sun, B. Louie, E. Evensen, B. B. Mittleman, A. Cesano, G. Cavet, C. O. Bingham, S. S. Cofield, J. R. Curtis, M. I. Danila, C. Raman, R. A. Furie, M. C. Genovese, W. H. Robinson, M. C. Levesque, L. W. Moreland, P. A. Nigrovic, N. A. Shadick, J. R. O’Dell, G. M. Thiele, E. W. S. Clair, C. C. Striebich, M. B. Hale, H. Khalili, F. R. Batliwalla, C. Aranow, M. Mackay, B. Diamond, G. P. Nolan, P. K. Gregersen and S. L. Bridges, Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity, PLoS One 16(1) (2021) Article ID e0244187 (18 pages); https://doi.org/10.1371/journal.pone.0244187
- Y. Yuan, N. Mu, Y. Li, J. Gu, C. Chu, X. Yu, J. Kang, T. Li, Y. Yan, H. Zhang, Y. Liu, H. Xu, C. Wang, D. Zhang, Q. Sun, W. Zhang, Z. Zheng, G. Feng and X. Xue, TNF-alpha promotes synovial inflammation and cartilage bone destruction in rheumatoid arthritis via NF-kappaB/YY1/miR-103a-3p axis, FASEB J. 39(14) (2025) Article ID e70876 (2 pages); https://doi.org/10.1096/fj.202501452R
- T. Schumertl, J. Lokau and C. Garbers, IL-6 signaling in immunopathology: From basic biology to selective therapeutic intervention, Immunotargets Ther. 14 (2025) 681–695; https://doi.org/10.2147/ITT.S485684
- H. S. Shamsnia, M. Roustaei, D. Ahmadvand, A. E. Butler, D. Amirlou, S. Soltani, S. Momtaz, T. Jamialahmadi, A. H. Abdolghaffari and A. Sahebkar, Impact of curcumin on p38 MAPK: Therapeutic implications, Inflammopharmacology 31(15) (2023) 2201–2212; https://doi.org/10.1007/s10787-023-01265-2
- T. Bobkova, A. Bobkov and Y. Li, Pharmacological inhibition of the PI3K/AKT/mTOR pathway in rheumatoid arthritis synoviocytes: A systematic review and meta-analysis (preclinical), Pharmaceuticals 18(8) (2025) Article ID 1152 (33 pages); https://doi.org/10.3390/ph18081152
- C. Qian, X. Cao and J. A. Hoffmann, Toll-like receptors in innate immunity and inflammation: From fundamental biology to clinic insights, Immun. Inflamm. 2(1) (2026) Article ID 22 (50 pages); https://doi.org/10.1007/s44466-026-00040-6
- A. D. Inchingolo, A. M. Inchingolo, G. Malcangi, P. Avantario, D. Azzollini, S. Buongiorno, F. Via-piano, M. Campanelli, A. M. Ciocia, N. De Leonardis, E. de Ruvo, I. Ferrara, G. Garofoli, V. Montenegro, A. Netti, G. Palmieri, A. Mancini, A. Patano, F. Piras, G. Marinelli, C. Di Pede, C. Laudadio, B. Rapone, D. Hazballa, A. Corriero, M. C. Fatone, A. Palermo, F. Lorusso, A. Scarano, I. R. Bordea, D. Di Venere, F. Inchingolo and G. Dipalma, Effects of resveratrol, curcumin and quercetin supplementation on bone metabolism – a systematic review, Nutrients 14(17) (2022) Article ID 3519 (39 pages); https://doi.org/10.3390/nu14173519
- S. H. Shahcheraghi, F. Salemi, N. Peirovi, J. Ayatollahi, W. Alam, H. Khan and L. Saso, Nrf2 regulation by curcumin: Molecular aspects for therapeutic prospects, Molecules 27(1) (2022) Article ID 167 (20 pages); https://doi.org/10.3390/molecules27010167
- M. M. Hanlon, T. McGarry, V. Marzaioli, S. Amaechi, Q. Song, S. Nagpal, D. J. Veale and U. Fearon, Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations, Rheumatology 62(7) (2023) 2611–2620; https://doi.org/10.1093/rheumatology/keac640
- W. He, J. Xu and X. Li, Macrophage polarization in inflammatory regulation: Molecular mechanisms, therapeutic targets, and translational challenges, Cell. Mol. Life Sci. 83(1) (2026) Article ID 9 (12 pages); https://doi.org/10.1007/s00018-025-06041-9
- Y. Peng, M. Zhou, H. Yang, R. Qu, Y. Qiu, J. Hao, H. Bi and D. Guo, Regulatory mechanism of M1/M2 macrophage polarization in the development of autoimmune diseases, Mediators Inflamm. 2023 (2023) Article ID 8821610 (20 pages); https://doi.org/10.1155/2023/8821610
- N. Iwamoto, K. Furukawa, Y. Endo, T. Shimizu, R. Sumiyoshi, M. Umeda, T. Koga, S. Y. Kawashiri, T. Igawa, K. Ichinose, M. Tamai, T. Origuchi and A. Kawakami, Methotrexate alters the expression of microRNA in fibroblast-like synovial cells in rheumatoid arthritis, Int. J. Mol. Sci. 22(21) (2021) Article ID 11561 (11 pages); https://doi.org/10.3390/ijms222111561
- C. Lee, M. J. Kim, A. Kumar, H. W. Lee, Y. Yang and Y. Kim, Vascular endothelial growth factor signaling in health and disease: From molecular mechanisms to therapeutic perspectives, Signal Transduct. Target. Ther. 10(1) (2025) Article ID 170 (40 pages); https://doi.org/10.1038/s41392-025-02249-0
- Y. Wang and D. W. Grainger, RNA therapeutics targeting osteoclast-mediated excessive bone resorption, Adv. Drug Deliv. Rev. 64(12) (2012) 1341–1357; https://doi.org/10.1016/j.addr.2011.09.002
- L. Yin, C. Sun, J. Zhang, Y. Li, Y. Wang, L. Bai and Z. Lei, Critical signaling pathways in osteoclast differentiation and bone resorption: Mechanisms and therapeutic implications for periprosthetic osteolysis, Front. Cell Dev. Biol. 13 (2025) Article ID 1639430 (18 pages); https://doi.org/10.3389/fcell.2025.1639430
- H. Zheng, Y. Deng, B. Li, J. Huang, J. Liu, Y. Yang, Y. Chen, L. Mao, Y. Li, Y. Liu, W. Wang and H. Yu, Xuetongsu attenuates bone destruction in rheumatoid arthritis by suppressing RANKL/RANK/NFATc1 pathway to inhibit osteoclastogenesis and bone resorption, Bone Joint Res. 14(11) (2025) 1016–1032; https://doi.org/10.1302/2046-3758.1411.BJR-2025-0259.R1
- M. Ahmadi, P. Bekeschus, K. D. Weltmann, K. von Woedtke and K. Wende, Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors, RSC Med. Chem. 13(5) (2022) 471–496; https://doi.org/10.1039/d1md00280e
- A. Rivera-Barahona, A. Fulgencio-Covian, C. Perez-Cerda, R. Ramos, M. A. Barry, M. Ugarte, B. Perez, E. Richard and L. R. Desviat, Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia, Sci. Rep. 7(1) (2017) Article ID 5727 (11 pages); https://doi.org/10.1038/s41598-017-06420-8
- A. Kumari, A. Kaur and G. Aggarwal, The emerging potential of siRNA nanotherapeutics in treatment of arthritis, Asian J. Pharm. Sci. 18(5) (2023) Article ID 100845 (23 pages); https://doi.org/10.1016/j.ajps.2023.100845
- K. A. Nikolova-Ganeva, N. M. Mihaylova, L. A. Kechidzhieva, K. I. Ivanova, A. S. Zarkov, D. L. Parzhanov, M. M. Ivanov and A. S. Marchev, The therapeutic potential of phytochemicals unlocks new avenues in the management of rheumatoid arthritis, Int. J. Mol. Sci. 26(14) (2025) Article ID 6813 (60 pages); https://doi.org/10.3390/ijms26146813
- J. W. Seo, S. H. Jo, S. H. Kim, B. H. Choi, H. Cho, J. J. Yoo and S. H. Park, Application of cartilage extracellular matrix to enhance therapeutic efficacy of methotrexate, Tissue Eng. Regen. Med. 21(2) (2024) 209–221; https://doi.org/10.1007/s13770-023-00587-0
- M. Kaurav, S. Ruhi, H. A. Al-Goshae, A. K. Jeppu, D. Ramachandran, R. K. Sahu, A. K. Sarkar, J. Khan and A. M. Ashif Ikbal, Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment, Front. Pharmacol. 14 (2023) Article ID 1159131 (20 pages); https://doi.org/10.3389/fphar.2023.1159131
- H. Nsairat, D. Khater, U. Sayed, F. Odeh, A. Al Bawab and W. Alshaer, Liposomes: Structure, composition, types, and clinical applications, Heliyon 8(5) (2022) Article ID e09394 (15 pages); https://doi.org/10.1016/j.heliyon.2022.e09394
- M. Rajabi and H. Feyzbakhsh, Polymeric nanocarriers in drug delivery, bioimaging, and biosensing: Advances and perspectives on nanomicelles, nanogels, and dendrimers, RSC Adv. 15(48) (2025) 40400–40438; https://doi.org/10.1039/d5ra05399d
- X. Tan, S. Wang, X. Zhou and M. Yang, Advances in the applications of stimulus-responsive nano-medicines for anti-cancer therapy, Nanomedicine 21(3) (2026) 449–466; https://doi.org/10.1080/17435889.2025.2598331
- H. Wu, G. Piao, Q. Chen, W. Luo, J. Liu, Y. Lan, Y. Wang, J. Zhou, K. Yang, J. Xiao, Q. Lv, S. Yang, W. Feng, G. Zhu, S. Tan and X. Hu, Hydrogels: Current biomedical applications and future directions, Mol. Biomed. 7(1) (2026) Article ID 25 (67 pages); https://doi.org/10.1186/s43556-026-00525-1
- M. Kwon and K. S. Kim, Nanofiber-based biomimetic platforms for chronic wound healing: Recent innovations and future directions, Tissue Eng. Regen. Med. 22(6) (2025) 755–770; https://doi.org/10.1007/s13770-025-00729-6
- Y. Deng, L. Liang, H. Lin, X. Shen, H. Zheng, Y. Deng, X. Tian, J. Huang, Y. Zhang, B. Li, H. Yu and W. Wang, Integrated LC-Orbitrap-MS and network pharmacology decipher the pharmacological basis of Eucommiae folium in treating rheumatoid arthritis, Mol. Divers. (2026); https://doi.org/10.1007/s11030-026-11495-5
- H. Zheng, J. Yang, Y. Deng, B. Zhang, F. Bai, Y. Chen, Y. Lu, B. Lian, J. Huang, Y. Yang, W. Wang and H. Yu, Kadsura coccinea extract alleviates rheumatoid arthritis via TNF-alpha suppression and gut microbiota modulation, J. Inflamm. Res. 19 (2026) Article ID 557108 (21 pages); https://doi.org/10.2147/JIR.S557108
- A. Yusuf, A. R. Z. Almotairy, H. Henidi, O. Y. Alshehri and M. S. Aldughaim, Nanoparticles as drug delivery systems: A review of the implication of nanoparticles’ physicochemical properties on responses in biological systems, Polymers 15(7) (2023) Article ID 1596 (26 pages); https://doi.org/10.3390/polym15071596
- R. Chijimatsu and T. Saito, Mechanisms of synovial joint and articular cartilage development, Cell. Mol. Life Sci. 76(20) (2019) 3939–3952; https://doi.org/10.1007/s00018-019-03191-5
- W. Li, Z. Ma, P. He, W. Xu, X. Liu, J. Yao, Q. Wu, P. Zou and T. Li, Taohong Siwu Decoction regulates MSC-mediated H-type angiogenesis to accelerate bone fracture healing through VHL/HIF-1alpha ubiquitination, Mediators Inflamm. 2026 (2026) Article ID 6551954 (22 pages); https://doi.org/10.1155/mi/6551954
- V. Di Nicola, Degenerative osteoarthritis a reversible chronic disease, Regen. Ther. 15 (2020) 149–160; https://doi.org/10.1016/j.reth.2020.07.007
- J. Lang, L. Li, Y. Quan, R. Tan, J. Zhao, M. Li, J. Zeng, S. Chen, T. Wang, Y. Li, J. Zhao and Z. Yin, LC-MS-based metabolomics reveals the mechanism of anti-gouty arthritis effect of Wuwei Shexiang pill, Front. Pharmacol. 14 (2023) Article ID 1213602 (16 pages); https://doi.org/10.3389/fphar.2023.1213602
- W. Saalfeld, A. M. Mixon, J. Zelie and E. J. Lydon, Differentiating psoriatic arthritis from osteoarthritis and rheumatoid arthritis: A narrative review and guide for advanced practice providers, Rheumatol. Ther. 8(4) (2021) 1493–1517; https://doi.org/10.1007/s40744-021-00365-1
- S. Jang, E. J. Kwon and J. J. Lee, Rheumatoid arthritis: Pathogenic roles of diverse immune cells, Int. J. Mol. Sci. 23(2) (2022) Article ID 905 (15 pages); https://doi.org/10.3390/ijms23020905
- J. Wu, X. Yan, M. Chen, H. Nie, Z. Yuan, F. L. Yuan and X. Li, Vascular-lymphatic dual circulation in bone health and disease: Mechanistic coupling and translational therapeutics, J. Orthop. Transl. 60 (2026) Article ID 101194 (25 pages); https://doi.org/10.1016/j.jot.2026.101194
- A. Mohammed, T. Alshamarri, T. Adeyeye, V. Lazariu, L. A. McNutt and D. O. Carpenter, A comparison of risk factors for osteo- and rheumatoid arthritis using NHANES data, Prev. Med. Rep. 20 (2020) Article ID 101242 (7 pages); https://doi.org/10.1016/j.pmedr.2020.101242
- Z. Zhang, X. Gao, S. Liu, Q. Wang, Y. Wang, S. Hou, J. Wang and Y. Zhang, Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20–54 years from 1990 to 2021, Sci. Rep. 15(1) (2025) Article ID 10736 (12 pages); https://doi.org/10.1038/s41598-025-92150-1
- A. L. Mueller, Z. Payandeh, N. Mohammadkhani, S. M. H. Mubarak, A. Zakeri, A. Alagheband Bahrami, A. Brockmueller and M. Shakibaei, Recent advances in understanding the pathogenesis of rheumatoid arthritis: New treatment strategies, Cells 10(11) (2021) Article ID 3017 (38 pages); https://doi.org/10.3390/cells10113017
- Z. Peng, W. Huang, M. Tang, B. Chen, R. Yang, Q. Liu, C. Liu and P. Long, Investigating the shared genetic architecture between hypothyroidism and rheumatoid arthritis, Front. Immunol. 14 (2023) Article ID 1286491 (10 pages); https://doi.org/10.3389/fimmu.2023.1286491
- M. Y. Ansari, N. Ahmad and T. M. Haqqi, Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols, Biomed. Pharmacother. 129 (2020) Article ID 110452 (24 pages); https://doi.org/10.1016/j.biopha.2020.110452
- X. Zhu and J. Zhu, CD4 T helper cell subsets and related human immunological disorders, Int. J. Mol. Sci. 21(21) (2020) Article ID 8011 (26 pages); https://doi.org/10.3390/ijms21218011
- M. Anandan and J. Narayanan, Role of T cells and cytokines in the pathogenesis of rheumatoid arthritis, Biochem. Biophys. Rep. 44 (2025) Article ID 102278 (18 pages); https://doi.org/10.1016/j.bbrep.2025.102278
- D. Wu, Y. Luo, T. Li, X. Zhao, T. Lv, G. Fang, P. Ou, H. Li, X. Luo, A. Huang and Y. Pang, Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment, Front. Immunol. 13 (2022) Article ID 1051082 (13 pages); https://doi.org/10.3389/fimmu.2022.1051082
- C. Barresi, F. Baldo, M. Menean, A. Marino, S. Costi, C. B. Chighizola, R. F. Caporali and E. Miserocchi, Juvenile idiopathic arthritis and associated uveitis: A review of pathogenesis, diagnosis, and management, Saudi J. Ophthalmol. 39(1) (2025) 31–40; https://doi.org/10.4103/sjopt.sjopt_153_24
- V. C. Romão and J. E. Fonseca, Disease mechanisms in preclinical rheumatoid arthritis: A narrative review, Front. Med. 9 (2022) Article ID 689711 (26 pages); https://doi.org/10.3389/fmed.2022.689711
- Y. Zhai, K. Wu, Q. Lin, Z. Cao, Y. Jia and P. Zhu, Post-translational modified neoantigens in autoimmune diseases: Challenges of immune tolerance, Adv. Sci. 12(34) (2025) Article ID e01766 (17 pages); https://doi.org/10.1002/advs.202501766
- A. Muheremu, S. Aierxiding and J. Gao, Regulation of the innate immune response in rheumatoid arthritis, Front. Immunol. 16 (2025) Article ID 1545625 (12 pages); https://doi.org/10.3389/fimmu.2025.1545625
- P. E. C. Brenchley, Angiogenesis in inflammatory joint disease: A target for therapeutic intervention, Clin. Exp. Immunol. 121(3) (2000) 426–429; https://doi.org/10.1046/j.1365-2249.2000.01299.x
- A. F. Radu and S. G. Bungau, Management of rheumatoid arthritis: An overview, Cells 10(11) (2021) Article ID 2857 (33 pages); https://doi.org/10.3390/cells10112857
- J. K. Park, B. Ghang, S. W. Han and J. H. Ju, Current and future treatment of rheumatoid arthritis, J. Rheum. Dis. 33(1) (2026) 7–18; https://doi.org/10.4078/jrd.2025.0034
- Y. Pan, X. Liu, S. Wang, L. Chen, A. Li, Q. Chi, X. Ku, K. Xu and C. Wang, Coniferyl aldehyde in ginger-Eucommiae Cortex enhances osteoarthritis treatment by modulating ALDOA and H3K23la histone lactylation, Phytomedicine 152 (2026) Article ID 157852 (5 pages); https://doi.org/10.1016/j.phymed.2026.157852
- D. Bobek, A. Banic Stipetic, M. Franic, M. Lucijanic, J. Lucijanic, A. Gudelj Gracanin, L. Mijacika and P. Peric, Use of non-steroidal anti-inflammatory drugs in patients with advanced active rheumatoid arthritis, Acta Clin. Croat. 61(4) (2022) 588–598; https://doi.org/10.20471/acc.2022.61.04.04
- M. Sagara, A. Majjad, H. Toufik and B. Ahmed, Impact of long-term glucocorticoid therapy on the response to biologic agents in rheumatoid arthritis: A prospective observational study, Cureus 17(12) (2025) Article ID e98824 (10 pages); https://doi.org/10.7759/cureus.98824
- J. Thomas, M. M. Kamso, S. L. Whittle, G. A. Wells, S. E. Kelly, J. Pardo Pardo, P. Tugwell, R. V. Johnston, V. Glennon, M. Ejaredar, M. Thomas, C. Lee, J. Elliott, A. Mokbel, J. C. Avery, L. Grobler, S. Cyril, R. Deardon, E. A. Akl, L. J. Maxwell, R. Buchbinder, G. S. Hazlewood and Cochrane Musculoskeletal H and Pain Thematic G, Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: A systematic review and network meta-analysis, Cochrane Database Syst. Rev. 7(7) (2026) Article ID CD013562 (5 pages); https://doi.org/10.1002/14651858.CD013562.pub2
- I. Padjen, M. R. Crnogaj and B. Anić, Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms, Reumatologia 58(6) (2020) 390–400; https://doi.org/10.5114/reum.2020.101400
- M. Riaz, G. Rasool, R. Yousaf, H. Fatima, N. Munir and H. Ejaz, Anti-rheumatic potential of biological DMARDs and protagonistic role of biomarkers in early detection and management of rheumatoid arthritis, Innate Immun. 31 (2025) Article ID 17534259251324820 (19 pages); https://doi.org/10.1177/17534259251324820
- K. K. Burashed and F. A. AlAbbasi, Janus kinase (JAK) inhibitors in rheumatoid arthritis, Cureus 18(1) (2026) Article ID e102634 (10 pages); https://doi.org/10.7759/cureus.102634
- R. Singh and A. P. Croft, Navigating complications of disease-modifying anti-rheumatic drugs at the ‘front door’, Clin. Med. 25(5) (2025) Article ID 100504 (4 pages); https://doi.org/10.1016/j.clinme.2025.100504
- M. Soura, A. Bakiri, G. E. Fragoulis and K. D. Vassilakis, Glucocorticoid-induced diabetes mellitus: Mechanisms, risk factors, and clinical pathways with insights from autoimmune rheumatic diseases, Rheumatol. Int. 46(4) (2026) Article ID 66 (11 pages); https://doi.org/10.1007/s00296-026-06099-z
- K. Wu, S. H. Kwon, X. Zhou, C. Fuller, X. Wang, J. Vadgama and Y. Wu, Overcoming challenges in small-molecule drug bioavailability: A review of key factors and approaches, Int. J. Mol. Sci. 25(23) (2024) Article ID 13121 (35 pages); https://doi.org/10.3390/ijms252313121
- T. Dixit, A. Vaidya and S. Ravindran, Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management, Future Sci. OA 11(1) (2025) Article ID 2467591 (17 pages); https://doi.org/10.1080/20565623.2025.2467591
- Q. Wang, X. Qin, J. Fang and X. Sun, Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies, Acta Pharm. Sin. B 11(5) (2021) 1158–1174; https://doi.org/10.1016/j.apsb.2021.03.013
- J. Wen, H. Li, H. Dai, S. Hua, X. Long, H. Li, S. Ivanovski and C. Xu, Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management, Mater. Today Bio. 19 (2023) Article ID 100597 (31 pages); https://doi.org/10.1016/j.mtbio.2023.100597
- S. D. Dwivedi, A. Bhoi, M. Pradhan, K. K. Sahu, D. Singh and M. R. Singh, Role and uptake of metal-based nanoconstructs as targeted therapeutic carriers for rheumatoid arthritis, 3 Biotech. 14(5) (2024) Article ID 142 (18 pages); https://doi.org/10.1007/s13205-024-03990-z
- J. Lu, X. Gao, S. Wang, Y. He, X. Ma, T. Zhang and X. Liu, Advanced strategies to evade the mono-nuclear phagocyte system clearance of nanomaterials, Exploration 3(1) (2023) Article ID 20220045 (19 pages); https://doi.org/10.1002/EXP.20220045
- V. H. Nguyen and B. J. Lee, Protein corona: A new approach for nanomedicine design, Int. J. Nano-medicine 12 (2017) 3137–3151; https://doi.org/10.2147/IJN.S129300
- X. Cheng, Q. Xie and Y. Sun, Advances in nanomaterial-based targeted drug delivery systems, Front. Bioeng. Biotechnol. 11 (2023) Article ID 1177151 (27 pages); https://doi.org/10.3389/fbioe.2023.1177151
- X. Li, B. Dai, J. Guo, L. Zheng, Q. Guo, J. Peng, J. Xu and L. Qin, Nanoparticle-cartilage interaction: Pathology-based intra-articular drug delivery for osteoarthritis therapy, Nano-Micro Lett. 13(1) (2021) Article ID 149 (48 pages); https://doi.org/10.1007/s40820-021-00670-y
- R. Allen and T. Yokota, Endosomal escape and nuclear localization: Critical barriers for therapeutic nucleic acids, Molecules 29(24) (2024) Article ID 5997 (21 pages); https://doi.org/10.3390/molecules29245997
- K. Knab, D. Chambers and G. Krönke, Synovial macrophage and fibroblast heterogeneity in joint homeostasis and inflammation, Front. Med. 9 (2022) Article ID 862161 (11 pages); https://doi.org/10.3389/fmed.2022.862161
- M. Ma, J. Di, C. Wang, Y. Xie, F. Cui, Y. Zhai, S. Zhu and J. Gao, Site-specific PEGylation of proteins: Insights into structural and functional changes, Acta Pharm. Sin. B 15(12) (2025) 6253–6273; https://doi.org/10.1016/j.apsb.2025.10.014
- R. Ben Mrid, N. Bouchmaa, H. Ainani, R. El Fatimy, G. Malka and L. Mazini, Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis, Biomed. Pharmacother. 151 (2022) Article ID 113126 (17 pages); https://doi.org/10.1016/j.biopha.2022.113126
- Z. Xu, Y. Xie, W. Chen and W. Deng, Nanocarrier-based systems for targeted delivery: Current challenges and future directions, MedComm. 6(9) (2025) Article ID e70337 (20 pages); https://doi.org/10.1002/mco2.70337
- M. A. Subhan, S. S. K. Yalamarty, N. Filipczak, F. Parveen and V. P. Torchilin, Recent advances in tumor targeting via EPR effect for cancer treatment, J. Pers. Med. 11(6) (2021) Article ID 571 (27 pages); https://doi.org/10.3390/jpm11060571
- P. Shi, Z. Cheng, K. Zhao, Y. Chen, A. Zhang, W. Gan and Y. Zhang, Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics, J. Nanobiotechnol. 21(1) (2023) Article ID 103 (27 pages); https://doi.org/10.1186/s12951-023-01826-1
- A. Shen, X. Cheng, Y. Cao and H. Deng, Multifunctional nanotherapeutics reprogramming the immunopathological landscape for rheumatoid arthritis therapy, Mater. Today Bio 35 (2025) Article ID 102379 (16 pages); https://doi.org/10.1016/j.mtbio.2025.102379
- A. Moretti, M. Paoletta, S. Liguori, W. Ilardi, F. Snichelotto, G. Toro, F. Gimigliano and G. Iolascon, The rationale for the intra-articular administration of clodronate in osteoarthritis, Int. J. Mol. Sci. 22(5) (2021) Article ID 2693 (16 pages); https://doi.org/10.3390/ijms22052693
- I. B. Belyaev, O. Y. Griaznova, A. V. Yaremenko, S. M. Deyev and I. V. Zelepukin, Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors, Adv. Drug Deliv. Rev. 219 (2025) Article ID 115550 (22 pages); https://doi.org/10.1016/j.addr.2025.115550
- R. Swami, P. Popli, K. Sal, R. R. Challa, B. Vallamkonda, M. Garg and C. P. Dora, A review on biomacromolecular ligand-directed nanoparticles: New era in macrophage targeting, Int. J. Biol. Macromol. 306(4) (2025) Article ID 141740 (6 pages); https://doi.org/10.1016/j.ijbiomac.2025.141740
- A. Gliszczynska and M. Nowaczyk, Lipid formulations and bioconjugation strategies for indo-methacin therapeutic advances, Molecules 26(6) (2021) Article ID 1576 (18 pages); https://doi.org/10.3390/molecules26061576
- M. Ferreira-Silva, C. Faria-Silva, P. Viana Baptista, E. Fernandes, A. Ramos Fernandes and M. L. Corvo, Liposomal nanosystems in rheumatoid arthritis, Pharmaceutics 13(4) (2021) Article ID 454 (25 pages); https://doi.org/10.3390/pharmaceutics13040454
- J. Karlsson, H. J. Vaughan and J. J. Green, Biodegradable polymeric nanoparticles for therapeutic cancer treatments, Annu. Rev. Chem. Biomol. Eng. 9 (2018) 105–127; https://doi.org/10.1146/annurevchembioeng-060817-084055
- S. Deng, M. R. Gigliobianco, R. Censi and P. Di Martino, Polymeric nanocapsules as nanotechno-logical alternative for drug delivery system: Current status, challenges and opportunities, Nano-materials 10(5) (2020) Article ID 847 (36 pages); https://doi.org/10.3390/nano10050847
- A. A. Chis, C. Dobrea, C. Morgovan, A. M. Arseniu, L. L. Rus, A. Butuca, A. M. Juncan, M. Totan, A. L. Vonica-Tincu, G. Cormos, A. C. Muntean, M. L. Muresan, F. G. Gligor and A. Frum, Applications and limitations of dendrimers in biomedicine, Molecules 25(17) (2020) Article ID 3982 (41 pages); https://doi.org/10.3390/molecules25173982
- J. M. Metselaar, L. M. Middelink, C. H. Wortel, R. Bos, J. M. van Laar, H. E. Vonkeman, R. Westhovens, T. Lammers, S. L. Yao, M. Kothekar, A. Raut and J. W. J. Bijlsma, Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial, J. Control. Release 341 (2022) 548–554; https://doi.org/10.1016/j.jconrel.2021.12.007
- R. Heo, D. G. You, W. Um, K. Y. Choi, S. Jeon, J. S. Park, Y. Choi, S. Kwon, K. Kim, I. C. Kwon, D. G. Jo, Y. M. Kang and J. H. Park, Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis, Biomaterials 131 (2017) 15–26; https://doi.org/10.1016/j.biomaterials.2017.03.044
- Q. Wang, J. Jiang, W. Chen, H. Jiang, Z. Zhang and X. Sun, Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis, J. Control. Release 230 (2016) 64–72; https://doi.org/10.1016/j.jconrel.2016.03.035
- P. Liu, G. Chen and J. Zhang, A review of liposomes as a drug delivery system: Current status of approved products, regulatory environments, and future perspectives, Molecules 27(4) (2022) Article ID 1372 (23 pages); https://doi.org/10.3390/molecules27041372
- J. Xin, J. Jichun and Y. Yonghai, Dexamethasone-loaded biodegradable magnetic microparticles for treatment of CFA-induced chronic pain in rats, Des. Monomers Polym. 25(1) (2022) 98–114; https://doi.org/10.1080/15685551.2022.2068743
- J. Hu, M. Shi, M. Tian, B. Xie, Y. Tan, D. Zhou, T. Qian and D. Qin, Nanomedicine-driven therapeutic strategies for rheumatoid arthritis-associated depression: Mechanisms and pharmacological progress, Pharmaceuticals 19(1) (2026) Article ID 94 (32 pages); https://doi.org/10.3390/ph19010094
- Q. Jiang, Z. Liu, J. Cheng, Z. Geng, Y. Gu, Y. Wei, M. Yu and Y. Bi, The antitumor potential of celastrol: Research progress on antitumor mechanisms and strategies for toxicity reduction with efficacy enhancement, Biomolecules 16(5) (2026) Article ID 620 (35 pages); https://doi.org/10.3390/biom16050620
- Q. Gao, H. Qin, L. Zhu, D. Li and X. Hao, Celastrol attenuates collagen-induced arthritis via inhibiting oxidative stress in rats, Int. Immunopharmacol. 84 (2020) Article ID 106527 (4 pages); https://doi.org/10.1016/j.intimp.2020.106527
- S. M. Bashir, G. Ahmed Rather, A. Patricio, Z. Haq, A. A. Sheikh, M. Shah, H. Singh, A. A. Khan, S. Imtiyaz, S. B. Ahmad, S. Nabi, R. Rakhshan, S. Hassan and P. Fonte, Chitosan nanoparticles: A versatile platform for biomedical applications, Materials 15(19) (2022) Article ID 6521 (28 pages); https://doi.org/10.3390/ma15196521
- Y. Hu, Q. Wu, Y. Wang, H. Zhang, X. Liu, H. Zhou and T. Yang, The molecular pathogenesis of triptolide-induced hepatotoxicity, Front. Pharmacol. 13 (2022) Article ID 979307 (13 pages); https://doi.org/10.3389/fphar.2022.979307
- C. Yu, H. Liu, C. Guo, Q. Chen, Y. Su, H. Guo, X. Hou, F. Zhao, H. Fan, H. Xu, Y. Zhao, X. Mu, G. Wang, H. Xu and D. Chen, Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis, Drug Deliv. 29(1) (2022) 454–465; https://doi.org/10.1080/10717544.2022.2032482
- Y. Wu, Y. Ge, Z. Wang, Y. Zhu, T. Tian, J. Wei, Y. Jin, Y. Zhao, Q. Jia, J. Wu and L. Ge, Synovium microenvironment-responsive injectable hydrogel inducing modulation of macrophages and elimination of synovial fibroblasts for enhanced treatment of rheumatoid arthritis, J. Nanobiotechnol. 22(1) (2024) Article ID 188 (17 pages); https://doi.org/10.1186/s12951-024-02465-w
- B. Gao, Z. Wang and W. Tan, Mannosylated nanocarriers: A precision targeting strategy for tumors and infectious diseases, Front. Pharmacol. 17 (2026) Article ID 1744292 (27 pages); https://doi.org/10.3389/fphar.2026.1744292
- M. M. Qadri, Targeting CD44 receptor pathways in degenerative joint diseases: Involvement of proteoglycan-4 (PRG4), Pharmaceuticals 16(10) (2023) Article ID 1425 (15 pages); https://doi.org/10.3390/ph16101425
- M. Zhou, J. Hou, Z. Zhong, N. Hao, Y. Lin and C. Li, Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy, Drug Deliv. 25(1) (2018) 716–722; https://doi.org/10.1080/10717544.2018.1447050
- Z. Guo, D. Liu, H. Zhang, W. Yu, Y. Li and N. Gu, Superparamagnetic iron oxide nanoparticles in clinical applications: Current status and future perspectives, EBioMedicine 122 (2025) Article ID 106054 (14 pages); https://doi.org/10.1016/j.ebiom.2025.106054
- L. M. Rogers, K. Firestone, R. Chinni, A. C. Branco, K. Wrobleski, T. Chou, J. A. Goldstein, X. Gu, E. Mason, S. Chu, M. R. der Lohe, P. Low and D. M. Aronoff, Folate receptor beta drives NLRP3 inflammasome activation and pyroptosis in macrophages independent of folate binding, J. Immunol. 215(4) (2026) Article ID vkag051 (46 pages); https://doi.org/10.1093/jimmun/vkag051
- Z. Tsitrouli, M. A. Akritidou, S. Genitsaris and G. V. Willigen, Treatment of rheumatoid arthritis with gene therapy applications: Biosafety and bioethical considerations, BioTech. 10(3) (2021) Article ID 11 (8 pages); https://doi.org/10.3390/biotech10030011
- A. Muravyeva and S. Smirnikhina, Strategies for modifying adenoviral vectors for gene therapy, Int. J. Mol. Sci. 25(22) (2024) Article ID 12461 (14 pages); https://doi.org/10.3390/ijms252212461
- A. M. Aldayel, H. L. O’Mary, S. A. Valdes, X. Li, S. G. Thakkar, B. E. Mustafa and Z. Cui, Lipid nanoparticles with minimum burst release of TNF-alpha siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate, J. Control. Release 283 (2018) 280–289; https://doi.org/10.1016/j.jconrel.2018.05.035
- T. Abaza, E. E. Mohamed and M. Y. Zaky, Lipid nanoparticles: A promising tool for nucleic acid delivery in cancer immunotherapy, Med. Oncol. 42(9) (2025) Article ID 409 (23 pages); https://doi.org/10.1007/s12032-025-02939-3
- M. Y. Al-Absi, A. E. Caprifico and G. Calabrese, Chitosan and its structural modifications for siRNA delivery, Adv. Pharm. Bull. 13(2) (2023) 275–282; https://doi.org/10.34172/apb.2023.030
- F. Machaj, M. Chmielewska-Jeznach, A. Koryszewska-Baginska, D. Malinowski, A. Pawlik and G. Oledzka, microRNAs as biomarkers and therapeutic targets in rheumatoid arthritis, Int. J. Mol. Sci. 26(20) (2025) Article ID 9950 (24 pages); https://doi.org/10.3390/ijms26209950
- W. Duan and H. Li, Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis, J. Nanobiotechnol. 16(1) (2018) Article ID 58 (9 pages); https://doi.org/10.1186/s12951-018-0382-x
- H. Wu, Y. He, H. Wu, M. Zhou, Z. Xu, R. Xiong, F. Yan and H. Liu, Near-infrared fluorescence imaging-guided focused ultrasound-mediated therapy against rheumatoid arthritis by MTX-ICG--loaded iRGD-modified echogenic liposomes, Theranostics 10(22) (2020) 10092–10105; https://doi.org/10.7150/thno.44865
- Y. Yang, L. Guo, Z. Wang, P. Liu, X. Liu, J. Ding and W. Zhou, Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization, Biomaterials 264 (2021) Article ID 120390 (6 pages); https://doi.org/10.1016/j.biomaterials.2020.120390
- S. Jain, T. H. Tran and M. Amiji, Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis, Biomaterials 61 (2015) 162–177; https://doi.org/10.1016/j.biomaterials.2015.05.028
- C. M. Chan, C. Y. Hsiao, H. J. Li, J. Y. Fang, D. C. Chang and C. F. Hung, The inhibitory effects of gold nanoparticles on VEGF-A-induced cell migration in choroid-retina endothelial cells, Int. J. Mol. Sci. 21(1) (2020) Article ID 109 (11 pages); https://doi.org/10.3390/ijms21010109
- O. M. Koo, I. Rubinstein and H. Onyuksel, Activly targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis, Pharm. Res. 28(4) (2011) 776–787; https://doi.org/10.1007/s11095-010-0330-4
- F. Zhao, Z. Hu, G. Li, M. Liu, Q. Huang, K. Ai and X. Cai, Angiogenesis in rheumatoid arthritis: Pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies, Bioact. Mater. 50 (2025) 603–639; https://doi.org/10.1016/j.bioactmat.2025.04.026
- S. M. Lee, H. J. Kim, Y. J. Ha, Y. N. Park, S. K. Lee, Y. B. Park and K. H. Yoo, Targeted chemo-photo-thermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles, ACS Nano 7(1) (2013) 50–57; https://doi.org/10.1021/nn301215q
- H. Lee, M. Y. Lee, S. H. Bhang, B. S. Kim, Y. S. Kim, J. H. Ju, K. S. Kim and S. K. Hahn, Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis, ACS Nano 8(5) (2014) 4790–4798; https://doi.org/10.1021/nn500685h
- G. Xiang, Y. Cui, P. Wang, Y. Feng, C. Zhang, J. Lou and X. Zhou, Nanomedicine targeting the PD-1/PD-L1 axis in autoimmune diseases: Breaking conventional barriers to restore immune tolerance, J. Nanobiotechnol. 23(1) (2025) Article ID 664 (26 pages); https://doi.org/10.1186/s12951-025-03766-4
- C. M. Weyand and J. J. Goronzy, The immunology of rheumatoid arthritis, Nat. Immunol. 22(1) (2021) 10–18; https://doi.org/10.1038/s41590-020-00816-x
- T. Zininga, L. Ramatsui and A. Shonhai, Heat shock proteins as immunomodulants, Molecules 23(11) (2018) Article ID 2846 (17 pages); https://doi.org/10.3390/molecules23112846
- B. G. Zhang, Q. Liu, T. Ma, J. J. Liu, Y. Zhang, F. Liu, X. M. Wen, D. X. Wang, W. Jiang and W. B. An, Mechanism and application of injectable hydrogel as carrier system in the treatment of osteoarthritis, Front. Bioeng. Biotechnol. 13 (2025) Article ID 1636518 (22 pages); https://doi.org/10.3389/fbioe.2025.1636518
- A. Gupta, J. Lee, T. Ghosh, V. Q. Nguyen, A. Dey, B. Yoon, W. Um and J. H. Park, Polymeric hydro-gels for controlled drug delivery to treat arthritis, Pharmaceutics 14(3) (2022) Article ID 540 (37 pages); https://doi.org/10.3390/pharmaceutics14030540
Language: English
Accepted on: Sep 15, 2026
Published on: Oct 23, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:
© 2026 Na Li, Zefang Qu, Daodong Du, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.